Genes in panel
STRs in panel
Prev Next

Genetic epilepsy syndromes

Gene: WASF1

Green List (high evidence)

WASF1 (WAS protein family member 1)
EnsemblGeneIds (GRCh38): ENSG00000112290
EnsemblGeneIds (GRCh37): ENSG00000112290
OMIM: 605035, Gene2Phenotype
WASF1 is in 3 panels

3 reviews

Rebecca Foulger (Genomics England curator)

I don't know

Review and rating collated by Tracy Lester (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust, 2019_02_06) on behalf of Wessex and West Midlands GLH for GMS Neurology specialist test group, for Clinical Indication R59 'Early onset or syndromic epilepsy'. Review contributors: John Taylor and Helen Lord. Suggested gene rating: Green.
Created: 6 Aug 2019, 8:38 p.m. | Last Modified: 6 Aug 2019, 8:38 p.m.
Panel Version: 1.189

Tracy Lester (Genetics laboratory, Oxford UK)

Green List (high evidence)

Reported in Ito et al 2018 - 3 de novo truncating variants were identified in 5 unrelated indivdiuals with moderate to profound intellectual disability with autistic features and seizures. (4/5).
Created: 6 Aug 2019, 8:31 p.m. | Last Modified: 6 Aug 2019, 8:31 p.m.
Panel Version: 1.188

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
intellectual disability

Publications

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Comment on mode of pathogenicity: Although the authors have suggested that the underlying disease mechanism is a gain-of-function or dominant-negative, the mode of pathogenicity has not been listed as such for this gene within PanelApp as the variants are all truncating and so will be identified using the loss of function criteria.
Created: 16 Jul 2018, 9:04 a.m.
From Ito Y, et al (2018) PMID: 29961568 "Identified de novo heterozygous truncating variants in WASF1 that caused a Neurodevelopmental disorder in individuals with Intellectual Disability associated with autistic features, seizures, and developmental delay. The three de novo variants, identified in five unrelated affected individuals from non-consanguineous families and are unrelated, are all predicted to affect the actin-binding C-terminal WCA region of WASF1. The clustering of truncating pathogenic variants reported here and the presence of a truncated protein in cells from affected individuals imply either a gain-of-function or dominant-negative mechanism of disease. The three variants were c.1516C>T (p.Arg506Ter), which occurred in three unrelated individuals, c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG (p.Ile494MetfsTer23). All three variants are predicted to partially or fully disrupt the C-terminal actin-binding WCA domain. Functional studies using fibroblast cells from two affected individuals with the c.1516C>T variant showed a truncated WASF1 and a defect in actin remodeling. The study provides evidence that de novo heterozygous variats in WASF1 cause a rare form of intellectual disability."

Although the authors have suggested that the underlying disease mechanism is a gain-of-function or dominant-negative the mode of pathogenicity has not been listed as such for this gene within PanelApp as the variants are all truncating and so will be identified using the loss of function criteria.
Created: 16 Jul 2018, 8:58 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
ID associated with autistic features, seizures, and developmental delay; Intellectual disability

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Wessex and West Midlands GLH
  • NHS GMS
  • Expert Review Green
  • Literature
Phenotypes
  • ID associated with autistic features, seizures, and developmental delay
  • Intellectual disability
OMIM
605035
Clinvar variants
Variants in WASF1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source Wessex and West Midlands GLH was added to WASF1.

6 Aug 2019, Gel status: 3

Added New Source

Rebecca Foulger (Genomics England curator)

Source NHS GMS was added to WASF1.

11 Dec 2018, Gel status: 3

Panel promoted to version 1.0

Sarah Leigh (Genomics England Curator)

Sarah Leigh: From Ito Y, et al (2018) PMID:

16 Jul 2018, Gel status: 3

Set mode of pathogenicity

Sarah Leigh (Genomics England Curator)

Mode of pathogenicity for gene: WASF1 was changed to None

16 Jul 2018, Gel status: 3

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: wasf1 has been classified as Green List (High Evidence).

16 Jul 2018, Gel status: 1

Added New Source

Sarah Leigh (Genomics England Curator)

WASF1 was added to Genetic Epilepsy Syndromes panel. Sources: Literature

16 Jul 2018, Gel status: 1

Created

Sarah Leigh (Genomics England Curator)

WASF1 was created by Sarah Leigh